Molecular diagnosis & therapyHumansHematopoietic Stem Cell TransplantationHematologic NeoplasmsDrug ApprovalHematopoietic Stem Cells
Dorocubicel: First Approval.
Arnold Lee
Published: 202610.1007/s40291-025-00824-3
Abstract
Dorocubicel (Zemcelpro®) is a cell therapy that includes UM171-expanded CD34+ haematopoietic stem cells derived from umbilical cord blood. It is being developed by Cordex Biologics for the treatment of haematological malignancies and non-malignant ha…
Preview only. Read the full abstract at the source